Company / Income Tax per Share
Nurix Therapeutics, Inc. Income Tax per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax per Share
$0.01
FY2025
5-year range
$0.00 / $0.01
FY2021-FY2025
Trend
+80.7%
vs FY2024
Sector context
#80 of 201
Health Care
What the data says
At $0.01, Nurix Therapeutics, Inc.'s income tax per share ranks #122 of 201 in the Health Care sector. Income Tax per Share has fluctuated over the past 7 years, ranging from $-5.71 in FY2020 to $0.07 in FY2019.
Based on SEC 10-K filings.
0.01 in FY2025 with a 3-year CAGR of +50.6%.
Increased from $0.00 to $0.01 over the past 2 years.
Health Care sector context is included.
Income Tax per Share over time
Growth rates
- 3-Year CAGR
- +50.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#122 of 201 in Health CareTop 60% of 201This company $0.01 Sector average $1.35
▼
-99.3% below sector average
Key checks
Key Insights
- In FY2025, income tax per share increased 80.7% year-over-year.
- Ranks #80 out of 201 companies in the Health Care sector.
- Peak income tax per share was recorded in FY2019.
- Lowest income tax per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -0.35 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income Tax per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.01 | +80.7% |
| FY2024 | $0.01 | - |
| FY2023 | $0.00 | -100.0% |
| FY2022 | $0.00 | -52.3% |
| FY2021 | $0.01 | +100.1% |
| FY2020 | -$5.71 | -7968.4% |
| FY2019 | $0.07 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026